Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1589.30
-20.85 (-1.29%)
< Home < Back

Sun Pharmaceutical reports 75% fall in Q3 consolidated net profit

Date: 14-02-2018

Sun Pharmaceutical Industries has reported results for third quarter ended December 31, 2017.

The company has reported net profit of Rs 40.50 crore for the quarter under review as against net loss of Rs 158.34 crore for the same quarter in the previous year. Total income of the company increased by 2.51% to Rs 2078.70 crore for Q3FY18 as compared Rs 2027.72 crore for the corresponding quarter previous year. 

On consolidate basis, the company has reported 75.17% fall in its net profit after taxes, share of profit of associates and joint ventures and non-controlling interest at Rs 365.39 crore for the quarter ended December 31, 2017 as compared to Rs 1,471.82 crore for the corresponding quarter in the FY17. Total consolidated income of the company decreased by 15.72% at Rs 6782.42 crore for quarter under review as compared to Rs 8047.26 crore for the same quarter ended previous year.